Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. (Q46402560)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2005
edit
Language Label Description Also known as
English
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
scientific article published in March 2005

    Statements

    Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit